Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.
about
STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activationIdentification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS geneLineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in miceBiomarkers in asthma: a real hope to better manage asthma.NO chemical events in the human airway during the immediate and late antigen-induced asthmatic responseSputum eosinophil apoptotic rate is positively correlated to exhaled nitric oxide in children.Redox control of asthma: molecular mechanisms and therapeutic opportunities.Pivotal role of c-Fos in nitric oxide synthase 2 expression in airway epithelial cells.Evolving Concepts of Asthma.Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy.Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthmaProteomic method identifies proteins nitrated in vivo during inflammatory challenge.An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthmaHuman airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.Characterization of inducible nitric oxide synthase expression in human airway epithelium.Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.Exhaled nitric oxide is decreased by exposure to the hyperbaric oxygen therapy environment.Nitric oxide metabolism in asthma pathophysiology.An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Nitric oxide in health and disease of the respiratory system.STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects.Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation.Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthmaCurrent concepts of severe asthma(R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.Proteomic analysis of the NOS2 interactome in human airway epithelial cellsNew Insights in Oxidant Biology in Asthma.Role of NOS2 in pulmonary injury and repair in response to bleomycin.Inducible nitric oxide synthase: what difference does it make?A novel method for pulmonary research: assessment of bioenergetic function at the air-liquid interface.Severe asthma: from characteristics to phenotypes to endotypes.Emerging molecular phenotypes of asthma.Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability.Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement.Neutrophilic Inflammation in Asthma and Association with Disease Severity.IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceRole of gamma interferon in Helicobacter pylori induction of inflammatory mediators during murine infection.Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction
P2860
Q24303982-BBA1E66C-0725-4F07-9C55-0856421C286EQ24540361-A034F649-C180-4B34-93D9-A8B4C4899969Q24671741-2F4CE98B-94A7-44BA-AF7A-AF9DB6D0A4E7Q28359512-D53A971E-87E1-409F-BF47-192DF318285EQ30417360-382F8386-6C72-4DFD-99E5-80FA55820A88Q30454236-057F89AF-D686-4620-B101-35780751F9A3Q33381264-8939F949-454E-4272-B7DE-5EF5E2309232Q33668491-49930569-C556-4604-9A92-9B489CDF7C06Q33725080-28AFBC4E-3709-4D71-8AFE-19ADD46AB2C9Q33735605-AC1D87D5-335E-40F0-B7A0-5864B2DDB6EDQ33761762-1DFC0C9E-451B-4253-842C-0DB2032227CAQ33804200-21E64B69-D934-4BF8-BF3F-403BA18F35F2Q33852115-84B96D98-E53D-478F-B544-889E32356E36Q33947294-859FD779-E0F5-4F0B-B903-1C8A66B96B6AQ34036478-DCAA0B5C-5737-4E0D-960A-2CBF5255085BQ34063491-E2E35B13-228B-48B9-80D8-135D00B9B7E1Q34941225-51288AF2-0D06-4C02-B110-AD2CFD5E59AFQ35083711-CCAE1C76-1550-480D-AE8D-9EA6BE9BFBBAQ35161457-471F3E25-FA06-4043-ABE4-B4DD977E2611Q35435319-70FA1A53-36B2-45F8-888F-73CB74002A88Q35534747-0DA7A44E-B7F0-4670-AD7D-8A5E008FF4C0Q35842979-FAEA6A31-5BA7-4BB1-B1A4-ECC96B53F02CQ36000599-E7BE470B-7499-476F-A71D-E3F99138B094Q36832237-54AECDB0-2118-4895-A0B2-D8F05180C01EQ36865999-7019E17C-DC8F-4831-97F4-C8647C593CA5Q37042266-57F20903-9905-415C-8045-03E7E6460D2DQ37101038-92C9DECA-4CD7-497A-B625-93D433A3D7C1Q37161361-BDCB5B15-A5F3-4F28-9D42-E83A237BB76FQ37241572-FB9CF3E8-26CF-4AB1-A653-6D54CB695654Q37330783-BC37FE91-BE6A-4421-805E-CF19B2E78614Q37374566-A98AE0AE-54B3-4D8D-B4F9-DC1ECC2D1D41Q37629319-10A2A882-9EC8-400B-A1A7-06861E1C8655Q37976476-A9CC0158-2746-4DF2-9EF7-89161B009E83Q38261186-1713BBBF-27F7-4D8A-915B-02DC6CA51142Q38307205-57F86A24-594D-49CF-9F44-D5960378BCECQ38311009-EAF574B4-EE2E-4A70-84BC-69323B0BE65BQ38645834-1EE2A0A9-E400-4424-BEE6-E2BD904F3331Q38780046-B5EA6F7F-93A4-40E8-9ED0-39AB356E280AQ39655101-16B54018-F3C5-4944-912E-DE61F1481FE3Q39792290-83E65482-CA57-4FEE-ABF6-9979AB8B64A5
P2860
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@en
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@nl
type
label
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@en
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@nl
prefLabel
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@en
Interferon gamma and interleuk ...... ynthesis of soluble mediators.
@nl
P2093
P2860
P356
P1476
Interferon gamma and interleuk ...... synthesis of soluble mediators
@en
P2093
P2860
P304
P356
10.1172/JCI119598
P407
P577
1997-08-01T00:00:00Z